Company Profile

Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:


Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Events & Presentations
Corporate Presentation
More information is coming soon.
Annual Report and Proxy Statement
Date Title and Summary
Toggle Summary Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PARK CITY, Utah --(BUSINESS WIRE)--Mar. 19, 2021-- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted inducement stock options, inducement performance restricted stock units ("PRSUs"), and inducement restricted stock units
Toggle Summary Arena Pharmaceuticals Reports Topline Results from Phase 2b CAPTIVATE Clinical Trial
- Olorinab investigated in three doses, 10 mg, 25 mg, and 50 mg, for abdominal pain associated with IBS-C & IBS-D - Trial did not meet primary endpoint in broad study population - Moderate to severe pain population at 50 mg showed statistically significant, clinically meaningful improvement vs